Heart Failure Clinical Trials in Albuquerque, New Mexico
5 studies are recruiting for heart failure in Albuquerque, New Mexico right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Participants include men and women ≥ 40 years of age with T2DM, established CV disease, a history of HTN with an SBP of at least 130 mmHg at screening, who meet the predefined serum potassium level, and with at least one additional risk factor for HF. The study will include an optional pre-screenin…
- Stage
- Phase 3
- Ages
- 40 and older
- Site
- Research Site, Albuquerque, New Mexico
- Locations
- 957 in total
- Run by
- AstraZeneca
-
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK…
- Stage
- Not phased
- Ages
- 0 to 20
- Site
- University of New Mexico Health Science Center, Albuquerque, New Mexico
- Locations
- 52 in total
- Run by
- Duke University
-
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
- Stage
- Not phased
- Ages
- Any age
- Site
- Research site, Albuquerque, New Mexico
- Locations
- 333 in total
- Run by
- Medtronic
-
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- New Mexico Heart Institute, Albuquerque, New Mexico
- Locations
- 68 in total
- Run by
- Abbott Medical Devices
-
Left vs Left Randomized Clinical Trial
The investigators aim to prospectively test the comparative effectiveness of His or Left bundle branch pacing in relation to patient centered outcomes (quality of life, physical activity, heart failure hospitalization, mortality) and comparative safety in relation to device-related complications an…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Lovelace Medical Center, Albuquerque, New Mexico
- Locations
- 71 in total
- Run by
- Baylor College of Medicine
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.